{"DataElement":{"publicId":"2739039","version":"1","preferredName":"Progressive Persistent Recurrent Disease Systemic Therapy And/Or Intrathecal Route of AdministrationTherapeutic Procedure Other Type Therapies Specify","preferredDefinition":"Cancer that is increasing in scope or severity._Retained; never-ceasing._the return of a sign, symptom, or disease after a remission._(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._Used to indicate that either or both of two items or options may be valid._Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Different than the one(s) previously specified or mentioned._Type; a subdivision of a particular kind of thing._the free text field related to therapy.","longName":"PRPD_SY_IN_TH_OTY_SP","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2739037","version":"1","preferredName":"Progressive Persistent Recurrent Disease Systemic Therapy And/Or Intrathecal Route of AdministrationTherapeutic Procedure Other Type","preferredDefinition":"Cancer that is increasing in scope or severity._Retained; never-ceasing._the return of a sign, symptom, or disease after a remission._(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._Used to indicate that either or both of two items or options may be valid._Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles._An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process._Different than the one(s) previously specified or mentioned._Type; a subdivision of a particular kind of thing.","longName":"PPRD_SY_O_IN_TH_O_TY","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2754328","version":"1","preferredName":"PD Persistent Recurrent Disease Systemic Therapy And/Or Intrathecal Route of Administration Therapeutic Procedure","preferredDefinition":"Cancer that is increasing in scope or severity.:Retained; never-ceasing.:the return of a sign, symptom, or disease after a remission.:(sis-TEM-ik THER-a-pee) Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.:Used to indicate that either or both of two items or options:Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C35571:C43623:C38155:C15698:C4","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Persistent","conceptCode":"C43623","definition":"Retained; never-ceasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Intrathecal Route of Administration","conceptCode":"C38267","definition":"Administration of drugs directly into spinal subarachnoid space in the cerebrospinal fluid, at any level of the cerebrospinal axis, including injection into the cerebral ventricles, in order to bypass the blood-brain barrier and achieve local, rapid effects on the meninges or cerebrospinal axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E76EC31-DB31-594B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-30","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-30","modifiedBy":"ONEDATA","dateModified":"2008-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2236666","version":"1","preferredName":"Other Type","preferredDefinition":"Different than the one(s) previously specified or mentioned. (NCI):A subdivision of a particular kind of thing.","longName":"C17649:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC571F-6DA8-4435-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A12DBBA-6134-3F28-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-04","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-04-04","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018810","version":"1","preferredName":"Therapies Specify","preferredDefinition":"the free text field related to therapy.","longName":"TX_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BA236E-6B3E-350B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"CAMPBELB","dateModified":"2008-03-28","changeDescription":"released as entered during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Specify the other systemic an","type":"Preferred Question Text","description":"Specify the other systemic and/or intrathecal therapy given for relapsed, persistent, or progressive disease since the date of the last report:","url":null,"context":"NHLBI"},{"name":"Specify other systemic / intrathecal therapy:","type":"Alternate Question Text","description":"Specify other systemic / intrathecal therapy:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A12FD40-FA45-4736-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-04","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-04-04","modifiedBy":"KUMMEROA","dateModified":"2011-05-11","changeDescription":"Removed alt name all_post_rlps_other_spec and CSI. Ak 5/11/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}